Dr. Jan Tavernier obtained his Ph.D. degree in 1984 on the cloning of interferon and interleukin genes. After an extended stay at Biogen and later at Roche, he returned in 1996 to Academia at the VIB Department of Medical Protein Research, Ghent University. He founded the Cytokine Receptor Laboratory that currently hosts over 40 researchers. Based on insights in cytokine receptor activation, he developed the mammalian MAPPIT two-hybrid technology and more recently the AcTakine concept. Detailed information can be found at www.crl-mappit.be.
Jan Tavernier published more than 200 refereed manuscripts, 20 of which are being cited over 100 times. He also holds 23 patent applications. His main areas of expertise are cytokine receptor activation and signal transduction, also linking to pathways involved in innate immunity, and the analysis of protein-protein interactions including interactome mapping, pathway walking and molecular description of domain interactions.
More info here.